Functional polymorphism of the NFKB1 gene promoter is not relevant in predisposition to celiac disease

References

• Green PH, Jabri B. Coeliac disease. Lancet 2003; 362(9381)383–91
   PubMed Web of Science ®Google Scholar
• Hadjivassiliou M, Williamson CA, Woodroofe N. The immunology of gluten sensitivity: beyond the gut. Trends Immunol 2004; 25: 578–82
   PubMed Web of Science ®Google Scholar
• Sollid LM. Coeliac disease: dissecting a complex inflammatory disorder. Nature Rev Immunol 2002; 2: 647
   PubMed Web of Science ®Google Scholar
• Chen LF, Greene WC. Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol 2004; 5: 392–401
   PubMed Web of Science ®Google Scholar
• Maiuri MC, De Stefano D, Mele G, Fecarotta S, Greco L, Troncone R, et al. Nuclear factor kappa B is activated in small intestinal mucosa of celiac patients. J Mol Med 2003; 81: 373–9
   PubMed Web of Science ®Google Scholar
• Jelinkova L, Tuckova L, Cinova J, Flegelova Z, Tlaskalova-Hogenova H. Gliadin stimulates human monocytes to production of IL-8 and TNF-alpha through a mechanism involving NF-kappaB. FEBS Lett 2004; 571: 81–5
   PubMed Web of Science ®Google Scholar
• Maiuri MC, De Stefano D, Mele G, Iovine B, Bevilacqua MA, Greco L, et al. Gliadin increases iNOS gene expression in interferon-gamma-stimulated RAW 264.7 cells through a mechanism involving NF-kappa B. Naunyn Schmiedebergs Arch Pharmacol 2003; 368: 63–71
   PubMed Web of Science ®Google Scholar
• Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem 1994; 269: 4705–8
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Arakawa T, Ueda N, Yamamoto S. Transcriptional roles of nuclear factor kappa B and nuclear factor-interleukin-6 in the tumor necrosis factor alpha-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells. J Biol Chem 1995; 270: 31315–20
   PubMed Web of Science ®Google Scholar
• Karban AS, Okazaki T, Panhuysen CI, Gallegos T, Potter JJ, Bailey-Wilson JE, et al. Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum Mol Genet 2004; 13: 35–45
   PubMed Web of Science ®Google Scholar
• Revised criteria for diagnosis of coeliac disease. Report of Working Group of the European Society of Paediatric Gastroenterology and Nutrition. Arch Dis Child 1990; 65: 909–11
   PubMed Web of Science ®Google Scholar
• Dudbridge F. Methods and software for association tests of uncertain haplotypes in case-parent trios. Am J Hum Genet 2002; 71 Suppl: A2338
   Google Scholar
• Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 2003; 25: 115–21
   PubMed Web of Science ®Google Scholar
• Gauderman WJ. Sample size requirements for association studies of gene-gene interaction. Am J Epidemiol 2002; 155: 478–84
   PubMed Web of Science ®Google Scholar
• Louka AS, Sollid LM. HLA in coeliac disease: unravelling the complex genetics of a complex disorder. Tissue Antigens 2003; 61: 105–17
   PubMed Web of Science ®Google Scholar
• Sollid LM. Molecular basis of celiac disease. Annu Rev Immunol 2000; 18: 53
   PubMed Web of Science ®Google Scholar
• Popat S, Bevan S, Braegger CP, Busch A, O'Donoghue D, Falth-Magnusson K, et al. Genome screening of coeliac disease. J Med Genet 2002; 39: 328–31
   PubMedGoogle Scholar
• Haimila K, Smedberg T, Mustalahti K, Maki M, Partanen J, Holopainen P. Genetic association of coeliac disease susceptibility to polymorphisms in the ICOS gene on chromosome 2q33. Genes Immun 2004; 5: 85–92
   PubMed Web of Science ®Google Scholar
• Rueda B, Martínez A, López-Nevot MA, Mas-Fontao A, Paco L, Ortega E, et al. A functional variant of IFN gamma gene is associated with coeliac disease. Genes Immun 2004; 5: 517–9
   PubMedGoogle Scholar
• Orange JS, Levy O, Geha RS. Human disease resulting from gene mutations that interfere with appropriate nuclear factor-kappaB activation. Immunol Rev 2005; 203: 21–37
   PubMedGoogle Scholar
• Guo D, Li M, Zhang Y, Yang P, Eckenrode S, Hopkins D, et al. A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes. Nat Genet 2004; 36: 837–41
   PubMed Web of Science ®Google Scholar
• Orozco G, Sanchez E, Collado MD, López-Nevot MA, Paco L, Garcia A, et al. Analysis of the functional NFKB1 promoter polymorphism in rheumatoid arthritis and systemic lupus erythematosus. Tissue Antigens 2005; 65: 183–6
   PubMedGoogle Scholar
• Oliver JG-GM, Paco L, López-Nevot MA, Piñero A, Correro F, Martin L, et al. A functional polymorphism of the NFKB1 promoter is not associated with ulcerative colitis in a Spanish population. Inflamm Bowel Dis 2005; 11: 576–9
   PubMed Web of Science ®Google Scholar
• Rueda B, López-Nevot MA, Ruiz MP, Ortega E, Maldonado J, Lopez M, et al. CA microsatellite polymorphism of the nuclear factor kappa B1 gene in celiac disease. Eur J Immunogenet 2004; 31: 129–32
   PubMedGoogle Scholar